Key result
Advances in congenital heart surgery substantially improve survival across complex defects.
Why the study?
Congenital heart surgery is a young and evolving field with ongoing advances in understanding, diagnostics, surgical techniques, and patient management improving outcomes.
Congenital heart surgery has evolved significantly since 1938, with advances in cardiopulmonary bypass and patient management leading to improved survival for complex defects.
Supports conservative PDA management in preterm infants per recent trials; leaves open optimal selection and timing for closure.
Congenital heart surgery is a young and constantly evolving field. Since the first patent ductus arteriosus ligation by Robert Gross of Boston in 1938, a greater understanding of the anatomy and pathophysiology of congenital heart disease, improved diagnostics, and the advent of cardiopulmonary bypass and deep hypothermic circulatory arrest have allowed the open repair of many lesions. Further advances in preoperative, intraoperative, and postoperative patient management have resulted in greatly improved survivals for even the most complex congenital defects. By looking forward through continual technical innovation and back with the critical evaluation of established techniques, we continue to advance the care of the patient with congenital heart disease.
No takes yet. Share an insight, caveat, or question.
Ohye et al. (2001) conducted a review in Congenital heart disease. Congenital heart surgery was evaluated. Continual technical innovations in congenital heart surgery and patient management have resulted in greatly improved survival for patients with even the most complex congenital defects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: